BIG PHARMA EARNINGS WATCH: PFIZER AND MERCK
Feb 5, 2026
Pfizer and Merck Beat Wall Street Expectations After Hiking Prices to Start… Read More
© 2026 CSRXP- All Rights Reserved
Updates
CSRxP APPLAUDS Q1/Q2 REFORMS ADVANCING TO PRESIDENT’S DESK, BIPARTISAN, MARKET-BASED SOLUTION WILL HELP INCREASE COMPETITION IN THE PRESCRIPTION DRUG MARKET
Feb 3, 2026
Congress Passes Reforms to Increase Transparency, Prevent Big Pharma from… Read More
BIG PHARMA EARNINGS WATCH: SANOFI
Feb 2, 2026
Sanofi Beats Wall Street Expectations, Touts Anti-Competitive Strategy on… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Jan 26, 2026
Johnson & Johnson Beats Wall Street Expectations; Raises Sales Forecasts… Read More
DOSE OF REALITY: NEW CMS DATA UNDERSCORES HOW BIG PHARMA’S EGREGIOUS PRICING PRACTICES ARE DRIVING INCREASED HEALTH CARE COSTS
Jan 26, 2026
U.S. Prescription Drug Spending Climbs as Big Pharma Sets New Records for… Read More
CSRxP APPLAUDS U.S. HOUSE PASSAGE OF Q1/Q2 REFORMS TO FOSTER GREATER COMPETITION IN THE PRESCRIPTION DRUG MARKETPLACE
Jan 22, 2026
Bipartisan, Market-Based Solution Would Increase Transparency… Read More
DOSE OF REALITY: BIG PHARMA’S EGREGIOUS PRICING AND ANTI-COMPETITIVE PRACTICES ARE DRIVING RISING HEALTH CARE COSTS
Jan 22, 2026
Making Health Care Affordable for the American People Means Holding Big Pharma… Read More
CSRxP LAUNCHES ADVERTISING CAMPAIGN HIGHLIGHTING BIG PHARMA’S EGREGIOUS PRACTICES THAT ARE ROOT CAUSE OF HIGH PRESCRIPTION DRUG PRICES, HEALTH CARE INFLATION
Jan 15, 2026
Campaign Introduces “Phil the Pill” as New Character Personifying How Big… Read More
CSRxP ANALYSIS: PHARMACEUTICAL INDUSTRY’S PROFIT MARGINS STILL 10 TIMES GREATER THAN OTHER SECTORS OF DRUG SUPPLY CHAIN
Jan 13, 2026
New Report Underscores How Brand Name Drug Companies Ride High on Egregious… Read More
DOSE OF REALITY: DRUG MAKERS INCREASINGLY UTILIZING DEVICE PATENTS TO EXTEND EXCLUSIVITY ON BLOCKBUSTER DRUGS
Jan 9, 2026
New Research Shows Drugmakers Increasingly Rely on Patents Disconnected from… Read More
DOSE OF REALITY: NEW REPORT PROJECTS MORE THAN 50 PERCENT DROP IN OUT-OF-POCKET COSTS FOR TOP MEDICARE DRUGS IN 2026
Jan 6, 2026
AARP Analysis Highlights Substantial Cost Savings for Nearly Nine Million… Read More
CSRxP STATEMENT ON THE PASSING OF DAVID MITCHELL
Jan 5, 2026
Founder and President of Patients for Affordable Drugs Was a Tireless and… Read More